Infection stimulates innate immune responses of insects, including activation of prophenoloxidase (proPO) in plasma as the last step of a serine protease cascade. To investigate the roles of protease inhibitors in regulating this pathway, we cloned cDNAs for two new serpins (serpin-4 and serpin-5) from the tobacco hornworm, Manduca sexta. Serpin-4 and serpin-5 mRNAs are constitutively expressed at a low level in larval hemocytes and fat body, and increase dramatically upon bacterial challenge. These serpins are present in larval plasma ~3 µg/ml (serpin-4) and ~1 µg/ml (serpin-5) and increase 3 to 8-fold by 24 h after injection of bacteria or fungi. Recombinant serpin-4 and serpin-5 decreased proPO activation when added to plasma, but they did not directly inhibit the proPOactivating proteases (PAPs). Instead, they apparently regulate the pathway by inhibiting one or more target proteases upstream of PAPs.
Prophenoloxidase (proPO) activation is an innate immune response in arthropods. Upon injury or infection, a proPO zymogen in plasma is activated by a specific protease. Phenoloxidase (PO) hydroxylates monophenols to o-diphenols and then oxidizes o-diphenols to quinones, which can polymerize to form melanin at the injury site or around invading organisms (1, 2) . Quinones may also be involved in the production of cytotoxic molecules such as superoxides and hydroxyl radicals that could help kill the invading organisms (1, 3) .
A serine protease cascade functions in proPO activation (2, 4, 5) . The final protease in the pathway, proPO-activating protease (PAP) (also called proPO activating enzyme or factor) has been identified from several insects, including the tobacco hornworm, Manduca sexta (6) (7) (8) , the silkworm, Bombyx mori (9), a beetle, Holotrichia diomphalia (10, 11) , and from a crustacean, the crayfish Pacifastacus leniusculus (12) . These PAPs contain one or two clip domains at their amino-terminus and a serine protease domain at their carboxyl-terminus (13) . PAPs are synthesized as zymogens, which are activated by a specific proteolytic cleavage between the clip domain and the protease domain. However, protease(s) that activate PAPs have not yet been characterized.
Serpins present in plasma regulate the proPO activation pathway (4, 5, (13) (14) (15) (16) . Serpins are serine protease inhibitors, about 400 amino acid residues long (17) (18) (19) (20) , with an exposed reactive center loop near their carboxyl-terminus (21, 22) . The P1 residue located in this loop determines the primary specificity of inhibition. Four serpins from M. sexta have been previously characterized. The serpin-1 gene encodes 12 variants with different inhibitory selectivity, due to alternative splicing of exons that encode the reactive center loop (23) (24) (25) . Serpin-1 mRNA is constitutively expressed in larval fat body and at a lower level in hemocytes (26) . One of the reactive site variants, serpin-1J, inhibits proPO activation in plasma by inhibiting PAPs (8, 25) . Serpin-2 is an intracellular protein (27) , expressed in cytoplasm of hemocytes after bacterial challenge. Its physiological function remains unknown. The serpin-3 gene encodes an immune-responsive serpin (28) that is expressed in fat body after bacterial challenge. Serpin-3 is present at a low level in larval plasma and increases dramatically in concentration after microbial challenge. Serpin-3 inhibits PAPs efficiently and blocks proPO activation in plasma. It appears to be a physiological regulator of the last step of the proPO activation pathway in M. sexta. (which has been purified from hemolymph but whose sequence has not yet been reported) selectively blocked proPO activation mediated by PAP-3 in vitro (29) .
Although our understanding of the proPO activation pathway in insects and other arthropods has increased during the last several years, we still do not know how many proteases are involved in the proPO activation pathway or how they are regulated. In this study, we report cDNA cloning and characterization of two new immuneresponsive serpins (serpin-4 and serpin-5) from M. sexta, which regulate proPO activation, apparently by inhibiting proteases upstream of PAPs in the activation cascade.
EXPERIMENTAL PROCEDURES
Insects-M. sexta larvae were from a laboratory colony started from eggs originally obtained from Carolina Biological Supply. Larvae were reared as described by Dunn and Drake (30) .
cDNA library screening-Partial cDNAs for serpin-4 and serpin-5 were identified as expressed sequence tags in the National Center for Biotechnology Information (NCBI) sequence database. A plasmid containing a 902 bp serpin-4 cDNA fragment (GenBank accession number BG835792) was obtained from Dr. Hugh M. Robertson, University of Illinois. A 286 bp serpin-5 cDNA fragment was amplified by PCR from clone N27 (BI262723) (31) . The purified cDNA fragments were labeled with [α- 32 P]-dCTP and used to screen a bacteria-induced M. sexta larval fat body cDNA library (7) . Positive plaques were purified and subcloned by in vivo plasmid excision. The cDNA inserts were sequenced using ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction Kit (Perkin Elmer Applied Biosystems).
Computer analysis of sequence data-The cDNA sequences of serpin-4 and serpin-5 were assembled and analyzed with the PileUp program of SeqWeb version 2 of the Genetics Computer Group (Accelrys Inc.). The secretion signal sequences were predicted with the SPScan program of SeqWeb version 2. The deduced amino acid sequences of serpin-4 and serpin-5 were used to search the databases of the NCBI with the BLAST program (32) . Protein sequence alignments were performed with the PileUp or Gap program of SeqWeb version 2.
Hemolymph collection-Day 2 fifth instar larvae were injected with 100 µl of filter-sterilized saline (0.85% NaCl), or 50 µg of Micrococcus luteus (Sigma), 1×10 8 formaldehyde-killed Escherichia coli, or 1×10 7 formaldehyde-killed Pichia pastoris suspended in 100 µl of saline. Hemolymph was collected into microcentrifuge tubes from injected individual larvae at 0, 1, 2, 6, 12, 24, 36, or 48 h after injection. A few crystals of diethyldithiocarbamate and phenylthiourea were added to the tubes before collection to prevent melanization of hemolymph. Hemocytes were removed from the hemolymph by centrifugation at 9000×g for 15 min at 4°C.
Northern blot analysis-Total RNA samples were isolated from hemocytes or fat body using an RNeasy Maxi Kit (QIAGEN). Northern blotting was performed using 20 µg of total RNA for each sample (33) . Full-length serpin-4 and serpin-5 cDNAs labeled with 32 P were used as probes. As a loading control, the membranes were re-hybridized with 32 P-labeled cDNA for M. sexta ribosomal protein S3 (34) .
Expression and purification of recombinant serpin-4 and serpin-5 in E. coli-The serpin-4B cDNA sequence encoding the mature secreted protein was amplified by PCR using forward and reverse primers: (5'-CATGTTCCATGGACGATTTACCTGCG-3', nucleotides 214-239 in Fig. 1A ) in which an NcoI site was introduced (underlined); 5'-GCACTAAGCATGCCATTCATG G-3', reverse complementary to nucleotides 1464-1485 (Fig. 1A) in which an SphI site was introduced (underlined). Similarly, the region encoding mature serpin-5A was amplified using 5'-CGTGTTCCATGGATGTGGATTT-3' (nucleotides 46-67, Fig. 1B ) in which an NcoI site was introduced (underlined) and a modified T7 primer (5'-TGAGCATGCGTAATACGA C-3') in which an SphI site was introduced (underlined). Serpin-5 cDNA clone 15A, which ends at nucleotide 1264 (Fig. 1B) was used as template. After NcoI-SphI digestion, the PCR products were inserted to the same restriction sites in plasmid H 6 pQE60 (35) . Plasmid DNA samples from resulting transformants were sequenced to confirm that the coding regions are in frame with the vector sequence encoding an N-terminal (His) 6 tag and do not contain any mutations.
The recombinant serpins were expressed in E. coli grown at 37°C in 2×YT medium containing 100 µg/µl of ampicillin and purified as described by Jiang et al. (36) with a few modifications. Medium for expressing serpin-5 was supplemented with 1% glycerol. When OD 600 of the cultures reached 1.0, serpin-4 and serpin-5 synthesis was induced with 0.1 mM isopropyl-β-D-thiogalactoside, with expression for 17 h at 25°C (serpin-4) or for 3 h at 37°C (serpin-5). The bacteria were harvested by centrifugation at 5500×g for 20 min and resuspended at 6 ml/mg pellet in lysis buffer (50 mM NaH 2 PO 4 , pH 8.0, 300 mM NaCl, 10 mM imidazole, 20 mM β-mercaptoethanol) and then incubated with lysozyme (1 mg/ml) for 30 min on ice. After sonication, the cell lysates were treated with RNase A (10 µg/µl) and DNase I (5 µg/µl) for 30 min on ice, and debris was removed by centrifugation. Serpins in the supernatants were purified by Ni-NTA agarose chromatography, with elution by buffer containing imidazole (150 mM for serpin-4 and 250 mM for serpin-5).
The affinity-purified serpins were dialyzed against 20 mM Tris-HCl, pH 8.0 and applied to a pre-equilibrated Q Sepharose Fast Flow column (1 cm × 10 cm). After washing with the buffer until post-column A 280 was near 0, proteins were eluted at 3 ml/min with a 140 ml 0-0.5 M linear gradient of NaCl in the same buffer. Fractions (3 ml each) were collected and subjected to SDS-PAGE and immunoblot analysis using antibody to penta-His (QIAGEN). The fractions containing serpins were pooled and concentrated. About 600 µg of each serpin was used as antigen for preparing a rabbit polyclonal antiserum (Cocalico Biologicals, Inc.).
Expression and purification of recombinant serpin-4 and serpin-5 in insect cells-The entire coding region for serpin-4B was amplified by PCR using forward and reverse primers (5'-CCGTGGAATTCCTCGTATAGC-3', nucleotides 102-122, EcoRI site underlined; 5'-TGCTCGAGTCATACCATTCATGG-3', reverse complementary to nucleotides 1464-1486, XhoI site underlined) (Fig. 1A) . Similarly, the entire serpin-5A coding sequence was amplified using 5'-CACACAGGAAACAGCTATGACC-3' (upstream of the T3 promoter in pBluescript-SK) and 5'-TATCGAACGATTTAATGT CGA CCT-3' (reverse complementary to nucleotides 1224-1247, SalI site underlined) (Fig. 1B) . The EcoRIXhoI and EcoRI-SalI fragments of the PCR products were inserted to the same restriction sites in pFastBac1 (Invitrogen Life Technologies). After DNA sequence verification, the plasmids were used to generate recombinant baculoviruses according to manufacturer's instructions.
For serpin-4 expression, Sf9 cells (2×10 6 cells/ml) in 100 ml Sf-900 II serum-free medium (Invitrogen Life Technologies) were infected with the recombinant baculovirus at multiplicity of infection of 2 and incubated at 28°C with shaking at 150 rpm in a 250-ml flask. The culture was harvested at 54 h after infection, and cells were removed by centrifugation at 5000×g for 20 min at 4°C. The expression of serpin-5 was the same except that 200 µl of protease inhibitor cocktail (Sigma, P8849) was added to 150 ml medium, and the culture was harvested at 48 h after infection.
To purify serpin-4 produced by Sf9 cells, the cell-free medium (600 ml) was applied to a Con A-Sepharose column (1.5 cm × 6 cm, Amersham Biosciences) at 1.5 ml/min. The column was washed with a binding buffer (20 mM Tris-HCl, pH 7.4, 0.5 M NaCl) at 4°C until A 280 was near 0. The proteins were eluted with 20 ml 0.5 M α-D-methylglucoside in the binding buffer at 1.25 ml/min, paused overnight and then continued, with collection of 2.5 ml fractions. Fractions containing serpin-4 were pooled, concentrated in a Macrosep Centrifugal Device (PALL Life Sciences), dialyzed against 20 mM Tris-HCl, pH 8.0, and applied to a pre-equilibrated Q-Sepharose Fast Flow column (1 cm × 10 cm, Amersham Biosciences). The column was washed with 20 mM Tris-HCl, pH 8.0 at 3.5 ml/min until A 280 was near 0 and then eluted with a linear gradient of NaCl (0-0.5 M, 140 ml) in 20 mM Tris-HCl, pH 8.0 at 2.25 ml/min. The 2.25-ml fractions were collected and analyzed by SDS-PAGE and immunoblot analysis. Serpin-5 was purified from the conditioned medium (2 liters) by the same protocol with minor changes. The Con A column was eluted with 1 M α-Dmethylmannoside, 1 M NaCl, 20 mM Tris-HCl, pH 7.4, and the Q-Sepharose column was eluted at 1 ml/min with a linear gradient of NaCl (0-0.16 M, 140 ml) in 20 mM Tris-HCl, pH 8.0, 10% ethylene glycol. (33) . Immunoblot analysis was carried out using 1:3000 diluted antisera (28) . Antibody binding was visualized using APconjugated goat-anti-rabbit IgG and AP Substrates Kit (Bio-Rad). Alternatively, antibody binding was revealed using HRP-conjugated goat-antirabbit IgG (Santa Cruz Biotechnology) and SuperSignal West Pico Chemiluminescent Substrate (PIERCE).
SDS-PAGE and immunoblot analysis-
Inhibitory activity assay-Concentrations of the purified inhibitors were determined using a Micro BCA Protein Assay Reagent Kit (PIERCE) with ovalbumin (Sigma) as a standard. Serpin-4 or serpin-5 was incubated with various commercial serine proteases or M. sexta prophenoloxidase activating proteases (PAP-1 or PAP-3) at different molar ratios in a total volume of 20 µl, 20 mM Tris-HCl, pH 8.0. Bovine serum albumin (4 µg) was included in the reactions, except for those containing cathepsin G or PAPs. Serpin was replaced by buffer in the control reaction. After incubation at room temperature for 10 min, 200 µl of the appropriate substrate solution in an assay buffer (50 mM Tris-HCl, pH 8.0, 50 mM NaCl) was added, and residual protease activity was measured by monitoring A 405 in a microplate reader (Bio-Tek Instrument, Inc.). One unit of amidase activity was defined as ∆A 405 /min = 0.001. For assaying PAPs, 5 mM CaCl 2 was included in the buffer. Thrombin activity was measured in 10 mM Tris-HCl, 50 mM NaCl, pH 8.0. The proteases and their artificial substrates were bovine pancreatic trypsin (5 ng, Sigma) and 100 µM N-acetyl-Ile-Glu-Ala-Arg-p-nitroanilide (Sigma or Biotechnology Microchemical Core Facility, Kansas State University); bovine pancreatic α-chymotrypsin (10 ng, Sigma) and 100 µM N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (Sigma); porcine pancreatic elastase (125 ng, Worthington) and 100 µM N-succinyl-Ala-AlaPro-Leu-p-nitroanilide (Sigma); human neutrophil cathepsin G (1 µg, ICN Biomedicals, Inc.) and 100 µM N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (Sigma); human plasmin (0.1 µg, ICN Biomedicals, Inc.) and 25 µM tosyl-Gly-Pro-Lysp-nitroanilide (Sigma); human serum thrombin (30 ng, Sigma) and 25 µM D-Phe-L-pipecolyl-Arg-pnitroanilide (Sigma); PAP-1 (25 ng) and 100 µM N-acetyl-Ile-Glu-Ala-Arg-p-nitroanilide; PAP-3 (40 ng) and 100 µM N-acetyl-Ile-Glu-Ala-Arg-pnitroanilide. Active PAP-1 and PAP-3 were isolated during purification of the recombinant proPAPs expressed in Sf9 cells (28, 37) .
ProPO activation and inhibition-To prepare a hemolymph sample suitable for proPO activation assays, hemolymph from 31 day 2 fifth instar larvae was collected from the cut dorsal horn into individual microcentrifuge tubes and immediately frozen at -80°C to prevent spontaneous melanization. A small aliquot of each hemolymph sample was thawed on ice, and 2 µl of hemolymph was incubated for 10 min at room temperature with 1 µl of filter-sterilized saline or M. luteus suspension (1 µg/µl in saline). PO activity was measured using dopamine as a substrate (7) . Hemolymph samples that had low basal PO activity and were activated dramatically by M. luteus were thawed on ice and pooled. The pooled hemolymph was centrifuged at 5500×g for 20 min at 4°C to remove any precipitate, including hemocytes. The supernatant was stored in aliquots at -80°C.
To investigate the effect of salt concentration on proPO activation, two µl of buffer (20 mM Tris-HCl, pH 8.0) containing different concentrations of NaCl was mixed first with 1 µl of M. luteus (2 µg/µl in saline), LPS from Salmonella minnesota smooth strain (Sigma) (1 µg/µl in water), E. coli strain XL1-blue (1×10 6 cells/µl in water), or laminarin from Laminaria digitata (Sigma) (0.2 µg/µl in water). Plasma samples (2 µl each) were added and incubated for 10 min at room temperature prior to PO activity measurement.
For inhibition assay, 2 µl of plasma was incubated for 5 min at room temperature with 2 µl of purified recombinant serpin-4 (in 20 mM TrisHCl, pH 8.0) or serpin-5 (in 20 mM Tris-HCl, 0.1 M NaCl, 10% ethylene glycol, pH 8.0) at varying concentration. Then M. luteus (1 µl, 2 µg/µl in saline) or E. coli XL1-blue (2 µl, 1×10
6 cells/µl in water) was added and incubated for another 10 min at room temperature before assay of PO activity.
Inhibition of proPAP activationReactions were set up as described above for the inhibition of proPO activation, with serpin-4 or serpin-5 at final concentration of 0.4 µg/µl and M. luteus at 0.4 µg/µl as an elicitor. A few crystals of diethyldithiocarbamate were included in the mixtures to prevent PO-catalyzed protein crosslinking. The reaction products were analyzed by SDS-PAGE and immunoblotting, using proPAP-1 or proPAP-3 antisera.
Results
cDNA cloning and sequence analysis-We used the M. sexta serpin-1 sequence to search the NCBI "other EST" database and identified expressed sequence tags from M. sexta, with high similarity to serpins but differing from previously characterized serpins. A partial cDNA clone from a M. sexta female antennae cDNA library (accession number: BG835792) showed high similarity to B. mori serpin-4 (accession number: AY566164). Using this 902-bp cDNA fragment as a probe, we screened a M. sexta bacteria-induced fat body cDNA library and isolated 10 positive clones from 3 × 10 5 plaques screened. The longest serpin-4 cDNA contains 3025 nucleotides, with a 176-bp 5' noncoding sequence, a 1221-bp open reading frame and a 1628-bp 3' noncoding sequence, including a 15-bp poly(A) tail (Fig. 1A) . . Two forms of the serpin-4 cDNA sequence were found (Fig. 1A) , with 49 nucleotide substitutions and several deletions or insertions in the 3' noncoding region. Three of the 14 substitutions in the coding region are nonsynonymous, but none of them are located in the predicted reactive center loop. The calculated molecular mass and isoelectric point of mature serpin-4A are 44,710 Da and 6.13, whereas those of serpin-4B are 44,688 Da and 6.30.
We identified a M. sexta cDNA fragment (accession number: BI262723) (31) that was very similar to B. mori serpin-5 (accession number: AY566165). Using the 286-bp M. sexta serpin-5 DNA as a probe, we screened the bacteria-induced fat body cDNA library and isolated 9 positive clones from 3 × 10 5 plaques screened. The longest cDNA insert is 1630 nucleotides long, with a 5-bp 5' noncoding region, a 1188-bp open reading frame, and a 437-bp 3' noncoding sequence, including a 22-bp poly(A) tail (Fig. 1B) . The open reading frame encodes 396 amino acid residues, including a 17-residue putative secretion signal peptide. The amino-terminal sequence of the mature serpin-5 was confirmed by Edman degradation (Tong et al., accompanying paper). There are two potential N-linked glycosylation sites at Asn 10 and Asn
173
. Two forms of serpin-5 cDNA were found (Fig. 1B) , with ten single nucleotide substitutions and several insertions or deletions in the 3' noncoding region. None of the five substitutions in the coding region alters the amino acid sequence. Serpin-5B cDNA has nine extra nucleotides just before the poly(A) tail, not present in serpin-5A, probably due to polyadenylation of the two forms at different positions. In the 3' noncoding region, there are three putative polyadenylation signals, two of which are very close to the poly(A) tail (Fig. 1B) . One serpin-5 cDNA clone ends at residue 1264 (Fig. 1B) followed by an 18-residue poly(A) tail, indicating that it used the first polyadenylation signal. The calculated molecular mass of mature serpin-5 is 42,740 Da. Its calculated isoelectric point is 6.54.
Sequence comparisons-Database searches and sequence alignments indicated that M. sexta serpin-4 is most similar in amino acid sequence to B. mori serpin-4, with 66.5% identity and 75.4% similarity. M. sexta serpin-5 is most similar to B. mori serpin-5, with 79.4% identity and 83.5% similarity. The high similarity in these apparent B. mori orthologs of serpin-4 and serpin-5 extends to the reactive center sequences. Serpin-4 and serpin-5 from both species have an Arg at the predicted P1 site, suggesting that they inhibit proteases that cleave after basic residues. Among the known M. sexta serpins, serpin-4 and serpin-5 are most similar to each other, with 37.0% identity and 47.9% similarity, and less similar (26-31% identity) to the other three serpins (Fig. 2) (27, 28, 38) . Among the D. melanogaster serpins, a serpin with accession number NP_649205 is the most similar to M. sexta serpin-4 (31.3% identity; 41.7% similarity) and serpin-5 (28.5% identity; 41.1% similarity). In serpins identified in the Anopheles gambiae genome, XP_312891 is most similar to M. sexta serpin-4 (32.3% identity; 45.2% similarity) and serpin-5 (29.0% identity; 45.0% similarity) Neither of these serpins has apparently been characterized further than genome sequencing.
Production of recombinant serpin-4 and serpin-5-We expressed recombinant serpin-4 and serpin-5 in E. coli with an amino-terminal (His) 6 tag. About 5% of serpin-4 and 20-30% of serpin-5 was soluble. The soluble serpins were purified by nickel-affinity chromatography followed by Q Sepharose anion exchange chromatography (Fig.  3) . About 2.4 mg of serpin-4 was purified from a 2 L E. coli culture, and 0.8 mg of serpin-5 from a 400 ml culture. For each serpin, part of the purified protein was used as an antigen to produce a polyclonal rabbit antiserum. Serpin-4 antibodies recognized one band from M. sexta larval plasma, whereas serpin-5 antibodies recognized two bands with slightly different sizes (Fig. 3B) . The slower migrating band was significantly more abundant.
We also expressed the two serpins in insect Sf9 cells using a baculovirus system. Both proteins were secreted into cell culture medium under control of their own secretion signal peptide sequence. The serpins were purified from the medium by Con A-Sepharose affinity chromatography and Q-Sepharose anion exchange chromatography. About 1 mg of serpin-4 was isolated from 650 ml of Sf9 cell culture. It had an apparent mass of 50.7 kDa (Fig. 3A) , which is greater than the calculated value of the deduced mature protein sequence (44.7 kDa). The difference is probably due to glycosylation, consistent with the binding of the recombinant protein to Con A. The natural serpin-4 protein in plasma had an apparent mass of 48.5 kDa, which is slightly smaller than that of the recombinant protein produced in Sf9 cells but larger than that of the (His) 6 -tagged protein (45.8 kDa) (Fig. 3A) , indicating that the natural protein is also probably glycosylated.
Four mg of serpin-5 was purified from 2 L of Sf9 cell culture. Two bands with slightly different mobilities were observed for recombinant serpin-5 produced in Sf9 cells (Fig. 3B) . The larger protein eluted from the Con A-Sepharose column slightly later than the lower one (data not shown), possibly due to higher extent of glycosylation. The serpin-5 doublet had apparent molecular masses of ~45.0 kDa, which is greater than the calculated value of the predicted mature protein (42.7 kDa) and also slightly larger than the natural serpin-5 in plasma (44.5 and 43.9 kDa) (Fig. 3B) . These results suggest that the plasma protein may also be differentially glycosylated.
The serpin-4 antibody specifically recognized recombinant serpin-4 produced in either E. coli or insect cells and natural serpin-4 in plasma (Figs. 3A and 4) . It had no cross-reactivity to serpin-1, serpin-3, or serpin-5 (Fig. 4) . Antibodies to serpin-1, serpin-3, and serpin-5 also reacted with their corresponding antigens and did not cross-react with the other three serpins, except that serpin-5 antibody weakly cross-reacted with serpin-4 (Fig. 4) .
Regulation of serpin-4 and serpin-5 expression in vivo-In Northern blot analysis, a 3.4 kb serpin-4 mRNA and a 1.9 kb serpin-5 mRNA were detected (Fig. 5 ), both consistent with the sizes of their cloned cDNAs. These mRNAs were present at a low level in hemocytes and fat body (the serpin-4 mRNA was detected as a faint band in the RNA sample from control hemocytes (CH) after longer exposure), and their levels increased dramatically at 24 h after larvae were injected with bacteria. Both serpins were expressed at considerably higher level in fat body than in hemocytes.
Serpin-4 protein was present in larval plasma at ~3 µg/ml (Fig. 6A) . After injection of larvae with saline, the serpin-4 concentration did not change significantly. Upon injection with M. luteus (Gram-positive bacterium), E. coli (Gramnegative bacterium), or P. pastoris (yeast), serpin-4 concentration increased significantly, reaching a maximum level of ~7 µg/ml by 24 h after injection, and remained high up to 48 h. Serpin-5 was detected in larval plasma at ~1 µg/ml (Fig. 6B) . No significant change in serpin-5 concentration was observed after saline injection. Upon injection with M. luteus or E. coli, serpin-5 concentration reached maxima of ~8 µg/ml and ~6 µg/ml, respectively, at 24 h after injection, and then decreased to ~4 µg/ml by 48 h. After injection with P. pastoris, serpin-5 level increased to ~4 µg/ml around 12 h, remained high up to 36 h, and then decreased to the basal level by 48 h.
Inhibitory activity of recombinant serpin-4 and serpin-5-Purified recombinant serpin-4 and serpin-5 produced in E. coli or Sf9 cells were tested for inhibition of commercial proteases and M. sexta PAPs. The (His) 6 -tagged serpin-4 had no inhibitory activity against thrombin, plasmin, chymotrypsin, cathepsin G, or elastase. It weakly inhibited trypsin by ~20% at a serpin/trypsin molar ratio of ~200:1 (data not shown). Serpin-4 produced in Sf9 cells behaved similarly (data not shown). Serpin-4 had some inhibitory activity against M. sexta PAP-1 and PAP-3, both of which cleave proPO at a specific Arg residue (6-8). However, serpin-4 did not inhibit the PAPs efficiently. Fifty percent inhibition occurred at serpin/protease ratio of 25:1 for PAP-1 and 40:1 for PAP-3 (Fig. 7A) .
Recombinant serpin-5 produced in E. coli inhibited trypsin by 50% at a serpin/protease molar ratio of 45:1, but had no activity against plasmin, thrombin, chymotrypsin, cathepsin G, or elastase (data not shown). Serpin-5 produced in Sf9 cells inhibited PAP-1 and PAP-3 by 50% at serpin-5/PAP molar ratio of ~13:1 and ~17:1, respectively (Fig. 7B) . It inhibited PAP-3 more efficiently (100% at 40:1, Fig. 7B ) than the protein from E. coli (~75% at 40:1, data not shown).
ProPO activation and inhibition-In order to study the physiological function of serpin-4 and serpin-5, we examined their effects on the proPO activation pathway. We first established a preparation suitable for proPO activation experiments and characterized its activation by microbial elicitors. We screened plasma samples from individual naïve larvae and identified 12 out of 31 individual samples that had low basal PO activity and could be activated dramatically by M. luteus. The other plasma samples had significant PO activity even before activation, and the activity did not increase much after incubation with bacteria. Perhaps the proPO in these samples had already been activated spontaneously or by contaminating microorganisms during hemolymph collection. When the 12 suitable plasma samples were pooled and assayed again for proPO activation, they still had low basal PO activity, and the activity in a 2-µl sample increased from less than 0.5 U to about 14 U in 10 min after activation by M. luteus. This indicated that the proPO activation cascade in this plasma preparation, readily activated by a bacterial elicitor, was suitable for testing inhibition of the pathway by serpins.
We examined the dependence of proPO activation on concentration of the elicitors M. luteus, LPS, and laminarin (Fig. 8A) . Under the experimental conditions tested, proPO activation reached a maximum at 0.1 µg/µl of M. luteus or LPS, and there was no significant increase in PO activity at higher concentrations. However, the concentration-dependence of proPO activation by laminarin differed significantly. Laminarin at 0.04 µg/µl activated proPO to a similar level as M. luteus or LPS did at 0.1 µg/µl. With increasing laminarin concentration, proPO activation decreased to a minimum at 0.4µg/µl and then increased at higher laminarin concentrations.
Salt concentration had different effects on proPO activation elicited by Gram-positive bacteria (M. luteus), Gram-negative bacteria (E. coli or LPS), or laminarin (Fig. 8B) . NaCl had the most dramatic effect on proPO activation by E. coli and LPS, less effect on proPO activation by laminarin, and least on proPO activation by M. luteus. The NaCl concentration-dependence curve for proPO activation by LPS or E. coli was sigmoidal, which differed from activation by M. luteus or laminarin. Changes in KCl concentration had nearly the same effect on proPO activation by LPS (data not shown). These results may indicate that distinct pathways (or branches) exist for proPO activation in response to different types of microorganisms, with reactions that differ in sensitivity to salt concentration.
To test their effect on proPO activation, we incubated different amounts of serpin-4 or serpin-5 with plasma for 5 min before adding M. luteus to initiate the protease cascade pathway. Serpin-4 at 68 ng/µl blocked proPO activation by 50% (Fig. 8C) . Recombinant serpin-4 produced in E. coli or Sf9 cells had a similar effect. Serpin-5 at 54 ng/µl suppressed proPO activation by 50% (Fig.  8D) . However, inhibition by serpin-5 leveled off around 60% at higher concentrations of serpin-5. The same phenomenon was observed when E. coli was used as an elicitor (Fig. 8D) . Since PAPs were not efficiently inhibited by either serpin, serpin-4 and serpin-5 each may inhibit at least one serine protease upstream of PAPs in the proPO activation pathway.
Inhibition of proPAP activation-To test whether serpin-4 and serpin-5 function upstream of PAPs, we examined inhibition of proPAP processing by serpin-4 and serpin-5 (Fig. 9) . A band representing proPAP-1 was present in naïve larval plasma and disappeared after incubation with M. luteus, coincident with the appearance of a band representing its catalytic domain and another band representing its clip domain. This result suggests the activation of proPAP-1 by proteolytic cleavage and is consistent with previous results (6, 8, 37) . However, when serpin-4 was added to the plasma, most of the proPAP-1 remained unchanged after incubation with a microbial elicitor, indicating that proPAP-1 cleavage was blocked by serpin-4. A similar effect on proPAP-3 activation by serpin-4 was observed (data not shown), although proPAP-3 was present at a very low concentration in naïve larval plasma. A faint band at ~70 kDa was detected by antibody to PAP-1 in all of the plasma samples, and its intensity was slightly greater in samples in which proPAP had been activated (lanes 2 and 4). This band likely represents a complex of active PAP-1 with one or more of the serpins known to inhibit it (serpin-1J and serpin-3) and indicates a small degree of spontaneous proPAP-1 activation in plasma treated only with saline. These results suggest that serpin-4 inhibits one or more proteases that function upstream of PAP-1 and PAP-3 in the proPO activation pathway and that inhibition of such enzymes prevents activation of PAPs. On the other hand, after plasma supplemented with serpin-5 was incubated with M. luteus, proPAP-1 and proPAP-3 processing still occurred (Fig. 9) . The result was not significantly different from the control, plasma stimulated with bacteria in the absence of added serpin-5. This result is consistent with the observation that proPO activation was only partially inhibited by serpin-5 ( Fig. 8D ) and suggests that serpin-5 and serpin-4 may function to inhibit different proteases in the proPO pathway.
DISCUSSION
Upon injury or infection in insects, protease cascades are activated, leading to the activation of zymogens of proteases, which in turn activate proPO. The proPO activation pathway appears to be regulated to prevent unnecessary activation and limit melanization to a short period of time at a discrete location. In M. sexta, this pathway is partly regulated by serpin-1J, serpin-3, and serpin-6, which efficiently inhibit PAPs (8, 28, 29) . Two serpins, Spn43Ac and Spn27A, are involved in regulation of proPO activation pathway in D. melanogaster (39) (40) (41) , but their target proteases have not yet been identified. The number and identity of proteases involved in the proPO activation pathway, how they are regulated, or how microbial components trigger the activation of the first protease in the pathway are not well understood in any arthropod species.
In this study, we have cloned cDNAs for two immune-responsive serpins, M. sexta serpin-4 and serpin-5. Their mRNAs are constitutively present at a low level in hemocytes and fat body and increase dramatically after microbial injection. Serpin-4 and serpin-5 proteins exist in larval plasma at a low concentration, which increase significantly after microbial injection. These data suggest that serpin-4 and serpin-5 function in the innate immune system to regulate proteases activated in response to infection.
Addition of recombinant serpin-4 or serpin-5 to plasma suppressed proPO activation considerably, but neither serpin inhibited the PAPs efficiently, requiring a high serpin/protease molar ratio for 50% inhibition. In contrast, serpin-3 inhibits PAP-3 completely at a serpin/protease molar ratio of 1.9:1 (28), and serpin-1J inhibits PAP-3 by 50% at 6.7:1 (8). PAP-1 can be completely inhibited by serpin-3 at a serpin/protease ratio of 1.6:1 (28). Thus, PAPs are not likely physiological targets of serpin-4 or serpin-5. Instead, these serpins may regulate proPO activation by inhibiting one or more proteases upstream of PAPs in the cascade. This is consistent with our observation that serpin-4 could suppress activation of proPAP in plasma.
Whereas serpin-4 completely blocked proPO activation, the pathway remained partially (~40%) active at high serpin-5 concentrations. This difference suggests that the activation pathway may be branched, with one branch A branched serine protease pathway may also exist in D. melanogaster adults, controlling immune responses to fungal or Gram-positive bacterial infection by activating the Toll pathway (43) . The Toll receptor binds a protein ligand called spätzle, which is activated by specific proteolysis. A loss-of-function mutation in the spn43Ac gene results in constitutive spätzle cleavage and Toll activation, indicating that the plasma serpin negatively regulates the Tollmediated immune response by inhibiting a serine protease involved in spätzle activation. A serine protease named Persephone functions upstream of spätzle and specifically responds to fungal infection (44) , as does Spn43Ac. Mutants of the persephone gene suppress the phenotype of Spn43Ac loss-of-function mutants. The activation of spätzle and Toll by Gram-positive bacteria, which apparently does not involve Persephone or Spn43Ac, suggests that a distinct branch of the protease cascade is activated by Gram-positive bacteria.
inhibited by both serpins 4 and 5 and another branch that is regulated by serpin-4 but lacking a protease inhibited by serpin-5. In an accompanying paper (Tong et al., 2004 ), we present data for identification of target proteases of serpin-4 or serpin-5 in plasma, which indicates that these two serpins inhibit some proteases in common and that serpin-4 also inhibits some additional plasma proteases that do not react with serpin-5.
The differential effects of salt concentration on proPO activation by Grampositive bacteria, Gram-negative bacteria, or β-1,3-glucan suggests that these microbial elicitors activate the pathway through mechanisms that involve some molecular interactions with different sensitivity to ionic strength. The sigmoidal curves may suggest a possible allosteric effect of NaCl on an activation step in the response to LPS or E. coli, which is absent in proPO activation elicited by Gram-positive bacteria or β-1,3-glucan. This difference might also be an indication that the proPO pathway is branched, with different types of microorganisms activating separate branches that converge to activate PAPs and proPO. The hemolymph coagulation pathway in horseshoe crabs, which is the best characterized serine protease cascade in an invertebrate innate immune response (42) is such a branched pathway. Four serine proteases (factor C, factor B, factor G, and clotting enzyme) and one clottable protein comprise a branched pathway in response to Gram-negative bacterial or fungal infection. LPSresponsive factor C and factor B form one branch while β-1,3-glucan-responsive factor G forms the other. Each branch generates active clotting enzyme that converts coagulogen to insoluble coagulin. This clotting pathway is regulated by three serpins, named limulus intracellular coagulation inhibitors (LICIs). LICI-1 inhibits factor C, LICI-2 inhibits factor C and clotting enzyme, and LICI-3 inhibits factor G.
Insect genomes are rich in serine proteases, including many clip domain proteases related to PAPs (13, 45) . There are 35 clip-domain protease genes in the D. melanogaster genome and 41 such genes in the mosquito A. gambiae (46) , and many of these are likely to be plasma proteins. Insect plasma also contains a complex mixture of serine protease inhibitors (14, 16) , including at least 16 serpins in M. sexta (serpins 3, 4, 5, 6, and 12 variants of serpin-1) (25, 28, 29) . Understanding the physiological functions of such a complex system will require further characterization of the hemolymph proteases and serpins and their roles in immunity, development, or other processes. Numbers on the left are assigned to nucleotide residues, and numbers on the right are assigned to amino acid residues, including negative numbers for residues in the secretion signal peptide, which are underlined. The amino-terminal sequences of the mature proteins are double-underlined. Potential Nlinked glycosylation sites (NXS/T) are shaded. The predicted reactive center loop is dash-underlined with the predicted P1 residue in bold. The putative polyadenylation signals, "AATAAA" or "ATTAAA", are double-underlined. Two forms of full-length cDNAs for each serpin were obtained. Substitutions, insertions, and deletions of nucleotide residues in serpin-4B and serpin-5B cDNAs are indicated in bold italic lower case letters above the sequences. Three amino acid substitutions in serpin-4B are indicated in boxes. Fig. 2 . Sequence alignment of known M. sexta serpins. The residues identical in all five sequences are highlighted in yellow, and residues which are identical or conservative substitutions in at least three of the sequences are highlighted in blue. The secretion signal peptide sequences are underlined, and residue numbers of the mature serpins are indicated. The putative reactive center loops (residues P16 to P5') are underlined, with the predicted scissile bond indicated by "⏐" between P1 (double-underlined) and P1' residues. Accession numbers: serpin-1J, AAC47340; serpin-2, AAB58491; serpin-3, AA021505; serpin-4, AY566163; serpin-5, AY566166. 5 cells/µl,) was added and incubated at room temperature for 10 min prior to the PO activity assay. In panels C and D, the basal PO activity of the plasma sample is shown as a bar (pre-activation). Error bars represent the standard deviation (n=4 for panels B and C; n=3 for panel D). 
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